2. Epigenetics
  3. Epigenetic Reader Domain
  4. 1172626-99-1

1172626-99-1

NRC-2694-A Chemical Structure

1172626-99-1

Chemical Structure

  • NRC-2694-A
  • CAS No: 1172626-99-1
    Formula: C24H27ClN4O3
    Molecular Weight: 454.95
  • InChIKey: YHFOWANFLQFAKF-UHFFFAOYSA-N
  • SMILES: COC1=CC2=NC=NC(NC3=CC=CC(C#C)=C3)=C2C=C1OCCCN4CCOCC4.Cl

Biological Activity: NRC-2694-A is an orally effective EGFR tyrosine kinase inhibitor. NRC-2694-A can be used in the study of malignant squamous cell carcinoma (HNSCC)[1].

Cat. No. Product Name Purity Description
HY-19909A NRC-2694-A NRC-2694-A is an orally effective EGFR tyrosine kinase inhibitor. NRC-2694-A can be used in the study of malignant squamous cell carcinoma (HNSCC).

References

[1]. Adkins D, et al. Oral NRC-2694-A in combination with paclitaxel as therapy for recurrent and/or metastatic head and neck squamous cell carcinoma (R/M-HNSCC) that progressed on or after an immune checkpoint inhibitor (ICI): A multi-center, single-arm, phase 2 trial. 2023.

Keywords:

NRC-2694-A